# Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

> **NCT00176059** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Giessen** · enrollment: 50 (actual)

## Conditions studied

- Renal Failure, Chronic
- Renal Transplantation

## Interventions

- **DRUG:** intravenous immunoglobulins (IVIG)
- **PROCEDURE:** kidney transplantation

## Key facts

- **NCT ID:** NCT00176059
- **Lead sponsor:** University of Giessen
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2007-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176059, "Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00176059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*